These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 7957231)

  • 1. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations.
    Beck-Sickinger AG; Wieland HA; Wittneben H; Willim KD; Rudolf K; Jung G
    Eur J Biochem; 1994 Nov; 225(3):947-58. PubMed ID: 7957231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogues with single D-residue substitutions.
    Kirby DA; Boublik JH; Rivier JE
    J Med Chem; 1993 Nov; 36(24):3802-8. PubMed ID: 8254609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships with neuropeptide Y analogues: a comparison of human Y1-, Y2- and rat Y2-like systems.
    Cox HM; Tough IR; Ingenhoven N; Beck-Sickinger AG
    Regul Pept; 1998 Sep; 75-76():3-8. PubMed ID: 9802388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
    Beck-Sickinger AG; Jung G
    Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types.
    Grundemar L; Kahl U; Callréus T; Langel U; Bienert M; Beyermann M
    Regul Pept; 1996 Apr; 62(2-3):131-6. PubMed ID: 8795076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bioactive conformation of neuropeptide Y analogues at the human Y2-receptor.
    Rist B; Ingenhoven N; Scapozza L; Schnorrenberg G; Gaida W; Wieland HA; Beck-Sickinger AG
    Eur J Biochem; 1997 Aug; 247(3):1019-28. PubMed ID: 9288927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
    Fournier A; Gagnon D; Quirion R; Cadieux A; Dumont Y; Pheng LH; St-Pierre S
    Mol Pharmacol; 1994 Jan; 45(1):93-101. PubMed ID: 8302286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel analogues of neuropeptide Y with a preference for the Y1-receptor.
    Söll RM; Dinger MC; Lundell I; Larhammer D; Beck-Sickinger AG
    Eur J Biochem; 2001 May; 268(10):2828-37. PubMed ID: 11358498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining structural requirements for neuropeptide Y receptors using truncated and conformationally restricted analogues.
    Kirby DA; Koerber SC; Craig AG; Feinstein RD; Delmas L; Brown MR; Rivier JE
    J Med Chem; 1993 Feb; 36(3):385-93. PubMed ID: 8426366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
    Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
    J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-affinity relationships of C-terminal cyclic analogue of neuropeptide Y for the Y1-receptor.
    Takebayashi Y; Koga H; Togami J; Kurihara H; Furuya T; Tanaka A; Murase K
    Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):1925-9. PubMed ID: 11145146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated, branched, and/or cyclic analogues of neuropeptide Y: importance of the pancreatic peptide fold in the design of specific Y2 receptor ligands.
    Reymond MT; Delmas L; Koerber SC; Brown MR; Rivier JE
    J Med Chem; 1992 Oct; 35(20):3653-9. PubMed ID: 1433176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions.
    Akerberg H; Fällmar H; Sjödin P; Boukharta L; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Regul Pept; 2010 Aug; 163(1-3):120-9. PubMed ID: 20471432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
    Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, receptor binding, and crosslinking of photoactive analogues of neuropeptide Y.
    Beck-Sickinger AG; Wieland HA; Brunner J
    J Recept Signal Transduct Res; 1995; 15(1-4):473-85. PubMed ID: 8903958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors.
    Grandt D; Schimiczek M; Rascher W; Feth F; Shively J; Lee TD; Davis MT; Reeve JR; Michel MC
    Regul Pept; 1996 Nov; 67(1):33-7. PubMed ID: 8952003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent labelled analogues of neuropeptide Y for the characterization of cells expressing NPY receptor subtypes.
    Ingenhoven N; Beck-Sickinger AG
    J Recept Signal Transduct Res; 1997; 17(1-3):407-18. PubMed ID: 9029504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclopeptide analogs for characterization of the neuropeptide Y Y2-receptor.
    Beck-Sickinger AG; Köppen H; Hoffmann E; Gaida W; Jung G
    J Recept Res; 1993; 13(1-4):215-28. PubMed ID: 8450492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor.
    Potter EK; Barden JA; McCloskey MJ; Selbie LA; Tseng A; Herzog H; Shine J
    Eur J Pharmacol; 1994 May; 267(3):253-62. PubMed ID: 8088364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.